261 related articles for article (PubMed ID: 23791010)
1. ALG3-CDG (CDG-Id): clinical, biochemical and molecular findings in two siblings.
Riess S; Reddihough DS; Howell KB; Dagia C; Jaeken J; Matthijs G; Yaplito-Lee J
Mol Genet Metab; 2013; 110(1-2):170-5. PubMed ID: 23791010
[TBL] [Abstract][Full Text] [Related]
2. Congenital disorder of glycosylation type Id (CDG Id): phenotypic, biochemical and molecular characterization of a new patient.
Rimella-Le-Huu A; Henry H; Kern I; Hanquinet S; Roulet-Perez E; Newman CJ; Superti-Furga A; Bonafé L; Ballhausen D
J Inherit Metab Dis; 2008 Dec; 31 Suppl 2():S381-6. PubMed ID: 18679822
[TBL] [Abstract][Full Text] [Related]
3. Expanding the phenotype, genotype and biochemical knowledge of ALG3-CDG.
Alsharhan H; Ng BG; Daniel EJP; Friedman J; Pivnick EK; Al-Hashem A; Faqeih EA; Liu P; Engelhardt NM; Keller KN; Chen J; Mazzeo PA; ; Rosenfeld JA; Bamshad MJ; Nickerson DA; Raymond KM; Freeze HH; He M; Edmondson AC; Lam C
J Inherit Metab Dis; 2021 Jul; 44(4):987-1000. PubMed ID: 33583022
[TBL] [Abstract][Full Text] [Related]
4. DPM2-CDG: a muscular dystrophy-dystroglycanopathy syndrome with severe epilepsy.
Barone R; Aiello C; Race V; Morava E; Foulquier F; Riemersma M; Passarelli C; Concolino D; Carella M; Santorelli F; Vleugels W; Mercuri E; Garozzo D; Sturiale L; Messina S; Jaeken J; Fiumara A; Wevers RA; Bertini E; Matthijs G; Lefeber DJ
Ann Neurol; 2012 Oct; 72(4):550-8. PubMed ID: 23109149
[TBL] [Abstract][Full Text] [Related]
5. ALG3-CDG: Report of two siblings with antenatal features carrying homozygous p.Gly96Arg mutation.
Lepais L; Cheillan D; Frachon SC; Hays S; Matthijs G; Panagiotakaki E; Abel C; Edery P; Rossi M
Am J Med Genet A; 2015 Nov; 167A(11):2748-54. PubMed ID: 26126960
[TBL] [Abstract][Full Text] [Related]
6. CDG-Id in two siblings with partially different phenotypes.
Kranz C; Sun L; Eklund EA; Krasnewich D; Casey JR; Freeze HH
Am J Med Genet A; 2007 Jul; 143A(13):1414-20. PubMed ID: 17551933
[TBL] [Abstract][Full Text] [Related]
7. Novel variants and clinical symptoms in four new ALG3-CDG patients, review of the literature, and identification of AAGRP-ALG3 as a novel ALG3 variant with alanine and glycine-rich N-terminus.
Himmelreich N; Dimitrov B; Geiger V; Zielonka M; Hutter AM; Beedgen L; Hüllen A; Breuer M; Peters V; Thiemann KC; Hoffmann GF; Sinning I; Dupré T; Vuillaumier-Barrot S; Barrey C; Denecke J; Kölfen W; Düker G; Ganschow R; Lentze MJ; Moore S; Seta N; Ziegler A; Thiel C
Hum Mutat; 2019 Jul; 40(7):938-951. PubMed ID: 31067009
[TBL] [Abstract][Full Text] [Related]
8. ALG3-CDG: lethal phenotype and novel variants in Chinese siblings.
Bian Y; Qiao C; Zheng S; Qiu H; Li H; Zhang Z; Yin S; Jiang H; Li-Ling J; Liu C; Lyu Y
J Hum Genet; 2020 Dec; 65(12):1129-1134. PubMed ID: 32655146
[TBL] [Abstract][Full Text] [Related]
9. Successful treatment of intractable epilepsy with ketogenic diet therapy in twins with ALG3-CDG.
Paketci C; Edem P; Hiz S; Sonmezler E; Soydemir D; Sarikaya Uzan G; Oktay Y; O'Heir E; Beltran S; Laurie S; Töpf A; Lochmuller H; Horvath R; Yis U
Brain Dev; 2020 Aug; 42(7):539-545. PubMed ID: 32389449
[TBL] [Abstract][Full Text] [Related]
10. Fetal glycosylation defect due to ALG3 and COG5 variants detected via amniocentesis: Complex glycosylation defect with embryonic lethal phenotype.
Ferrer A; Starosta RT; Ranatunga W; Ungar D; Kozicz T; Klee E; Rust LM; Wick M; Morava E
Mol Genet Metab; 2020 Dec; 131(4):424-429. PubMed ID: 33187827
[TBL] [Abstract][Full Text] [Related]
11. ALG3-CDG: a patient with novel variants and review of the genetic and ophthalmic findings.
Farolfi M; Cechova A; Ondruskova N; Zidkova J; Kousal B; Hansikova H; Honzik T; Liskova P
BMC Ophthalmol; 2021 Jun; 21(1):249. PubMed ID: 34090370
[TBL] [Abstract][Full Text] [Related]
12. Molecular partners of hNOT/ALG3, the human counterpart of the Drosophila NOT and yeast ALG3 gene, suggest its involvement in distinct cellular processes relevant to congenital disorders of glycosylation, cancer, neurodegeneration and a variety of further pathologies.
Hacker B; Schultheiß C; Döring M; Kurzik-Dumke U
Hum Mol Genet; 2018 Jun; 27(11):1858-1878. PubMed ID: 29547901
[TBL] [Abstract][Full Text] [Related]
13. ALG1-CDG: a new case with early fatal outcome.
Rohlfing AK; Rust S; Reunert J; Tirre M; Du Chesne I; Wemhoff S; Meinhardt F; Hartmann H; Das AM; Marquardt T
Gene; 2014 Jan; 534(2):345-51. PubMed ID: 24157261
[TBL] [Abstract][Full Text] [Related]
14. CDG-Id caused by homozygosity for an ALG3 mutation due to segmental maternal isodisomy UPD3(q21.3-qter).
Schollen E; Grünewald S; Keldermans L; Albrecht B; Körner C; Matthijs G
Eur J Med Genet; 2005; 48(2):153-8. PubMed ID: 16053906
[TBL] [Abstract][Full Text] [Related]
15. Defining the phenotype in congenital disorder of glycosylation due to ALG1 mutations.
Morava E; Vodopiutz J; Lefeber DJ; Janecke AR; Schmidt WM; Lechner S; Item CB; Sykut-Cegielska J; Adamowicz M; Wierzba J; Zhang ZH; Mihalek I; Stockler S; Bodamer OA; Lehle L; Wevers RA
Pediatrics; 2012 Oct; 130(4):e1034-9. PubMed ID: 22966035
[TBL] [Abstract][Full Text] [Related]
16. ALG12-CDG: novel glycophenotype insights endorse the molecular defect.
Sturiale L; Bianca S; Garozzo D; Terracciano A; Agolini E; Messina A; Palmigiano A; Esposito F; Barone C; Novelli A; Fiumara A; Jaeken J; Barone R
Glycoconj J; 2019 Dec; 36(6):461-472. PubMed ID: 31529350
[TBL] [Abstract][Full Text] [Related]
17. Deficiency of dolichol-phosphate-mannose synthase-1 causes congenital disorder of glycosylation type Ie.
Imbach T; Schenk B; Schollen E; Burda P; Stutz A; Grunewald S; Bailie NM; King MD; Jaeken J; Matthijs G; Berger EG; Aebi M; Hennet T
J Clin Invest; 2000 Jan; 105(2):233-9. PubMed ID: 10642602
[TBL] [Abstract][Full Text] [Related]
18. Novel ALG12 variants and hydronephrosis in siblings with impaired N-glycosylation.
Hiraide T; Wada Y; Matsubayashi T; Kadoya M; Masunaga Y; Ohkubo Y; Nakashima M; Okamoto N; Ogata T; Saitsu H
Brain Dev; 2021 Oct; 43(9):945-951. PubMed ID: 34092405
[TBL] [Abstract][Full Text] [Related]
19. Guanosine diphosphate-mannose:GlcNAc2-PP-dolichol mannosyltransferase deficiency (congenital disorders of glycosylation type Ik): five new patients and seven novel mutations.
Dupré T; Vuillaumier-Barrot S; Chantret I; Sadou Yayé H; Le Bizec C; Afenjar A; Altuzarra C; Barnérias C; Burglen L; de Lonlay P; Feillet F; Napuri S; Seta N; Moore SE
J Med Genet; 2010 Nov; 47(11):729-35. PubMed ID: 20679665
[TBL] [Abstract][Full Text] [Related]
20. ALG12-CDG: An unusual patient without intellectual disability and facial dysmorphism, and with a novel variant.
de la Morena-Barrio ME; Sabater M; de la Morena-Barrio B; Ruhaak RL; Miñano A; Padilla J; Toderici M; Roldán V; Gimeno JR; Vicente V; Corral J
Mol Genet Genomic Med; 2020 Aug; 8(8):e1304. PubMed ID: 32530140
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
